Cargando…

Cancer-Associated Carbohydrate Antigens as Potential Biomarkers for Hepatocellular Carcinoma

Hepatocellular carcinoma (HCC) is one of the most common human malignancies. Therefore, developing the early, high-sensitivity diagnostic biomarkers to prevent HCC is urgently needed. Serum a-fetoprotein (AFP), the clinical biomarker in current use, is elevated in only ∼60% of patients with HCC; the...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wu, Chen-Shiou, Yen, Chia-Jui, Chou, Ruey-Hwang, Li, Shiou-Ting, Huang, Wei-Chien, Ren, Chien-Tai, Wu, Chung-Yi, Yu, Yung-Luen
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2012
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3396621/ https://www.ncbi.nlm.nih.gov/pubmed/22808038 http://dx.doi.org/10.1371/journal.pone.0039466

Ejemplares similares

Development of a Highly Sensitive Glycan Microarray for Quantifying AFP-L3 for Early Prediction of Hepatitis B Virus–Related Hepatocellular Carcinoma
por: Wu, Chen-Shiou, et al.
Publicado: (2014)

EZH2-mediated epigenetic silencing of tumor-suppressive let-7c/miR-99a cluster by hepatitis B virus X antigen enhances hepatocellular carcinoma progression and metastasis
por: Wu, Chen-Shiou, et al.
Publicado: (2023)

Eye-Hand Synergy and Intermittent Behaviors during Target-Directed Tracking with Visual and Non-visual Information
por: Huang, Chien-Ting, et al.
Publicado: (2012)

Evaluation of a Rapid Antigen Test for the Diagnosis of SARS-CoV-2 during the COVID-19 Pandemic
por: Cheng, Chih-Chien, et al.
Publicado: (2022)

Epigenetic Silencing of miR-9 Promotes Migration and Invasion by EZH2 in Glioblastoma Cells
por: Chien, Yi-Chung, et al.
Publicado: (2020)

Heterophile carbohydrate antigen N‐glycolylneuraminic acid as a potential biomarker in patients with hepatocellular carcinoma
por: Akimoto, Shuji, et al.
Publicado: (2023)

Trajectory Adjustments Underlying Task-Specific Intermittent Force Behaviors and Muscular Rhythms
por: Chen, Yi-Ching, et al.
Publicado: (2013)

Fatigue Effect on Low-Frequency Force Fluctuations and Muscular Oscillations during Rhythmic Isometric Contraction
por: Lin, Yen-Ting, et al.
Publicado: (2014)

Dual-task walking improvement with enhanced kinesthetic awareness in Parkinson’s disease with mild gait impairment: EEG connectivity and clinical implication
por: Huang, Cheng-Ya, et al.
Publicado: (2022)

Applying NGS Data to Find Evolutionary Network Biomarkers from the Early and Late Stages of Hepatocellular Carcinoma
por: Wong, Yung-Hao, et al.
Publicado: (2015)

Characterization of Information-Based Learning Benefits with Submovement Dynamics and Muscular Rhythmicity
por: Hwang, Ing-Shiou, et al.
Publicado: (2013)

Analysis of MUC6 Genetic Variants on the Clinicopathologic Characteristics of Patients with Hepatocellular Carcinoma
por: Lee, Hsiang-Lin, et al.
Publicado: (2022)

HBx sensitizes hepatocellular carcinoma cells to lapatinib by up-regulating ErbB3
por: Chen, Jhen-Yu, et al.
Publicado: (2015)

Hepatitis B Virus X Protein Upregulates mTOR Signaling through IKKβ to Increase Cell Proliferation and VEGF Production in Hepatocellular Carcinoma
por: Yen, Chia-Jui, et al.
Publicado: (2012)

Unique Features of Hepatitis B Virus-Related Hepatocellular Carcinoma in Pathogenesis and Clinical Significance
por: Wang, Sheng-Han, et al.
Publicado: (2021)

Targeting the EGFR/PCNA Signaling Suppresses Tumor Growth of Triple-Negative Breast Cancer Cells with Cell-Penetrating PCNA Peptides
por: Yu, Yung-Luen, et al.
Publicado: (2013)

Progesterone receptor membrane component 1 as a potential prognostic biomarker for hepatocellular carcinoma
por: Tsai, Hung-Wen, et al.
Publicado: (2018)

Targeting EMP3 suppresses proliferation and invasion of hepatocellular carcinoma cells through inactivation of PI3K/Akt pathway
por: Hsieh, Yi-Hsien, et al.
Publicado: (2015)

Clinical Efficacy of Polycaprolactone β-Calcium Triphosphate Composite for Osteoconduction in Rabbit Bone Defect Model
por: Chen, Chiu-Ming, et al.
Publicado: (2021)

Carbohydrate antigen 19-9 as a serum marker of hepatocellular carcinoma: comparison with alpha-foetoprotein.
por: Kew, M. C., et al.
Publicado: (1987)

The Function of the Mutant p53-R175H in Cancer
por: Chiang, Yen-Ting, et al.
Publicado: (2021)

Precision health in Taiwan: A data-driven diagnostic platform for the future of disease prevention
por: Hsiao, Wesley Wei-Wen, et al.
Publicado: (2022)

dBMHCC: A comprehensive hepatocellular carcinoma (HCC) biomarker database provides a reliable prediction system for novel HCC phosphorylated biomarkers
por: Chu, Yen-Wei, et al.
Publicado: (2020)

Effect of national curriculum reform on medical students’ preparedness for practice: a prospective cohort study from undergraduate to postgraduate periods
por: Chaou, Chung-Hsien, et al.
Publicado: (2022)

Characterization of a new murine cell line of sarcomatoid hepatocellular carcinoma and its application for biomarker/therapy development
por: Yen, Chia-Hung, et al.
Publicado: (2017)

Variations in Static Force Control and Motor Unit Behavior with Error Amplification Feedback in the Elderly
por: Chen, Yi-Ching, et al.
Publicado: (2017)

Improving Precision Force Control With Low-Frequency Error Amplification Feedback: Behavioral and Neurophysiological Mechanisms
por: Hwang, Ing-Shiou, et al.
Publicado: (2019)

Visual Effect on Brain Connectome That Scales Feedforward and Feedback Processes of Aged Postural System During Unstable Stance
por: Chen, Yi-Ching, et al.
Publicado: (2021)

The Associations between Polysomnographic Parameters and Memory Impairment among Patients with Obstructive Sleep Apnea: A 10-Year Hospital-Based Longitudinal Study
por: Chien, Wei-Chen, et al.
Publicado: (2023)

Somatic mutations of PREX2 gene in patients with hepatocellular carcinoma
por: Yang, Ming-Hui, et al.
Publicado: (2019)

A highly selective and potent CXCR4 antagonist for hepatocellular carcinoma treatment
por: Song, Jen-Shin, et al.
Publicado: (2021)

Carbohydrate antigen 19-9 as a novel prognostic biomarker in distal cholangiocarcinoma
por: Jiang, Tao, et al.
Publicado: (2021)

SUMO-Activating Enzyme Subunit 1 (SAE1) Is a Promising Diagnostic Cancer Metabolism Biomarker of Hepatocellular Carcinoma
por: Ong, Jiann Ruey, et al.
Publicado: (2021)

Smurf2-mediated degradation of EZH2 enhances neuron differentiation and improves functional recovery after ischaemic stroke
por: Yu, Yung-Luen, et al.
Publicado: (2013)

The effect of propranolol on the prognosis of hepatocellular carcinoma: A nationwide population-based study
por: Chang, Ping-Ying, et al.
Publicado: (2019)

Optical coherence tomography and imaging biomarkers as outcome predictors in diabetic macular edema treated with dexamethasone implant
por: Chou, Hung-Da, et al.
Publicado: (2022)

Carbohydrate antigen 125 and carcinoembryonic antigen in the differentiation of tuberculous peritonitis and peritonitis carcinomatosa
por: Tong, Huan, et al.
Publicado: (2017)

Total HLA Class I Antigen Loss with the Downregulation of Antigen-Processing Machinery Components in Two Newly Established Sarcomatoid Hepatocellular Carcinoma Cell Lines
por: Lei, Wei-Yi, et al.
Publicado: (2018)

Alpha-Fetoprotein as a Potential Surrogate Biomarker for Atezolizumab + Bevacizumab Treatment of Hepatocellular Carcinoma
por: Zhu, Andrew X., et al.
Publicado: (2022)

Role of carbohydrate antigen 19-9, carcinoembryonic antigen, and carbohydrate antigen 125 as the predictors of resectability and survival in the patients of Carcinoma Gall Bladder
por: Agrawal, Saumya, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_c7cms8t8hphlnhb9d0m9i6egsm